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AbstrAct
Background A mutation in the canine multidrug 
resistance MDR1 gene (also referred as ABCB1), encoding 
for the multidrug resistance (MDR) P- glycoprotein (P- gp) 
transponder, causes a pathological condition known as 
‘ivermectin toxicosis’. The causative mutation, known 
since 2001, has been described to affects sheep herding 
breeds related to collie lineage. The present study is 
a retrospective investigation of the presence of MDR1 
mutated allele in Italian dog populations in a 5 years’ 
time lapse. The aim of the research is to offer a deep 
knowledge in MDR1 allelic and genotypic frequencies in 
canine breeds and populations raised in Italy.
Methods Genotype data for the 4- bp deletion 
(c296_299del4) in MDR1 gene from 811 dogs belonging to 
32 breeds/populations were collected.
Results The mutated allele has been found in 9 out of 31 
breeds: Rough Collie, Smooth Collie, Border Collie, Bearded 
Collie, Shetland Sheepdog, Australian Shepherd, White 
Swiss Shepherd, Old English Sheepdog, Whippet and also 
in crossbreed. The breeds with the highest allelic mutation 
frequency are Smooth and Rough Collies with 75 per cent 
and 66 per cent of mutant MDR1 allele, respectively.
Conclusions The results support the usefulness of this 
genetic analysis to optimise medical care in dogs at risk 
of multidrug resistance and to create an objective basis in 
breeding programme definition and in the risk evaluation 
in different breeds.
IntRoduCtIon
Ivermectin toxicosis is a pathological condi-
tion, first observed in shepherd dog breed 
in the 19th century in UK,1 caused by a 
mutation in the canine multidrug resistance 
MDR1 (also referred as ABCB1). This gene 
encodes for a glycoprotein2: the multidrug 
resistance (MDR) P- glycoprotein (P- gp) tran-
sponder. This is an ATP- driven multidrug 
efflux carrier2 3 belonging to the group of 
membrane- bound ATP- binding cassette tran-
sponder. The evident clinical signs of the 
neurotoxic effect promoted by the dysfunc-
tion of P- gp, caused by the expression of the 
mutant MDR1 gene, could even lead to coma 
and death.3
P- gp plays an important role in physio-
logical barriers. In the blood/brain barrier, 
it limits drug efflux in the central nervous 
system whereas in placental trophoblast it 
reduces drug access to fetal circulation and 
in Sertoli cells barrier it limits drug entry in 
gonads.3
Pharmacogenetic investigation of MDR1 
gene plays a pivotal role in purebred dog 
breed studies considering the basic function 
of P- gp in restricting the xenobiotics’ access.4 
The risk of intrinsic and acquired multidrug 
resistance in clinical therapy with particular 
attention to cancer treatment has been first 
described more than 30 years ago by Ueda 
and colleagues.5
The causative mutation was first described 
in 2001 by Mealey and colleagues who 
demonstrated the association of ivermectin 
sensitivity in collies with a deletion mutation 
in MDR1 gene. The mutation consists in a 
4- bp deletion (c296_299del4), leading to the 
expression of a truncated P- gp protein (7 per 
cent of the wild- type P- gp).6
The mutation has been described to affect 
sheep herding breeds related to collie lineage 
(Rough Collie—RoC, Smooth Collie—SmC, 
Border Collie—BoC, Bearded Collie—BeC, 
Shetland Sheepdog—ShS, Australian Shep-
herd—AuS) or not (German Shepherd—
GeS, White Swiss Shepherd—WSS, Old 
English Sheepdog—OES); furthermore, 
MDR1 polymorphism has been described 
in some sighthounds (Whippet—Whi), 
in some ENCI- FCI (Ente Nazionale della 
Cinofilia Italiana—Federation Cynologique 
International) unofficial breeds (Miniature 
Australian Shepherd—MAS, Silken Wind-
hund—SiW, Waller—Wal, McNab—McN) 
and in crossbreed (Cro).3 7
The present study is a retrospective inves-
tigation of the presence of MDR1 mutated 
allele in Italian dogs from 2012 to 2017. At 
present, it is the first survey about mutation 
distribution in Italy. The aim of the work is 
to offer a deep knowledge of the presence of 
this mutation in canine breeds and in cross-
breed in Italy to raise awareness among veter-
inarians to optimise medical care in dogs at 
risk of multidrug resistance and to create an 
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Table 1 List of samples tested for MDR1 mutation
Breed and acronym
Samples
N
Afghan Hound AfH 1
American Staffordshire Terrier AST 2
Australian Cattle Dog ACD 2
Australian Kelpie AuK 3
Australian Shepherd AuS 202
Bearded Collie BeC 10
Belgian Shepherd BeS 4
Bernese Mountain Dog BMD 1
Border Collie BoC 208
Borzoi Bor 2
Central Asia Shepherd Dog CAS 1
Crossbreed Cro 31
Czechoslovakian Wolfdog CzW 2
Dobermann Dob 1
English Bulldog EnB 1
Flat Coated Retriever FCR 1
German Shepherd GeS 3
Labrador Retriever LaR 1
Maltese Mal 1
Mudi Mud 1
Old English Sheepdog OES 12
Rottweiler Rot 1
Rough Collie RoC 190
Saarloos Wolfhound SaW 1
Schipperkee Sch 1
Shetland Sheepdog ShS 86
Shih Tzu 1
Smooth Collie SmC 6
Tibetan Mastiff 1
Welsh Corgi Pembroke 2
Whippet Whi 5
White Swiss Shepherd Dog WSS 27
objective basis in breeding programme definition and in 
the risk evaluation in different breeds.
MateRIals and Methods
Genotypic data at MDR1 locus of 811 (M: 382; F: 429) 
dogs from 32 populations (31 breeds+1 crossbreed) were 
analysed. Table 1 shows the number of dogs analysed per 
population.
Sample processing and analysis were carried out by 
Vetogene SRL, one of the official reference laboratories 
for the Italian Kennel Club ENCI (FCI associate), who 
collected all the samples through the years (from 2012 
to 2017), and provided the genotyping analysis and data 
for the present work. Vetogene extracted DNA from 100 
to 200 µL whole blood samples using the commercial 
kit Qiagen DNeasy Blood & Tissue kit (Qiagen, Hilden, 
Germany). All samples were sent for the genetic test anal-
ysis by veterinarians who certified the identification of the 
sample through microchip control. The presence of the 
causative mutation of 4- bp deletion (c.296_299del4) in 
the MDR1 gene (GenBank AF045016) was tested by PCR, 
in Vetogene Lab, using specific primers as described by 
Baars and colleagues in 2008. Data were analysed using 
the SAS V.9.4 statistical software package PROC FREQ, 
a procedure to calculate genotypic and allelic frequen-
cies per breed.8 The obtained results have been classified 
as the frequencies of MDR1 with homozygous wild type 
(+/+; clear), heterozygous (+/−; carrier), homozygous 
mutant (−/−; affected). Moreover, the frequency of the 
mutated allele MDR1 was calculated in the breed with 
almost five analysed animals (table 2).
Results
MDR1 mutated allele has been found in nine breeds 
(SmC, RoC, AuS, ShS, Whi, OES, WSS, BeC, BoC) listed 
in table 2 together with sample size. The sample size 
reflects the census of each breed in Italy.
The breeds with the highest mutated allele frequency 
are SmC and RoC with 75 per cent and 66 per cent of the 
MDR1 mutated allele, respectively. It is worth mentioning 
that tested SmC were 6, according to the low number of 
new registered dogs per year in Italy: 8 puppies entered 
in the Italian studbook in 2017.
In the sample of 202 AuS analysed dogs, the MDR1 
mutated allele showed a frequency of 35 per cent, while 
41 per cent of the analysed dogs did not present the 
mutated allele. The affected dogs are 11 per cent and the 
frequency of carriers (48 per cent) is one of the highest 
observed in the Italian analysed breeds. The presence 
trend of the mutant allele increased since 2012; further-
more, in 2017, AuS is the breed with the highest number 
of analysed dogs with 67 tested samples on a yearly entry 
of 2086 puppies in 2017.
In the tested sample of 86 ShS dogs, the frequency of 
the causative mutation of multidrug resistance gene was 
23 per cent, and a much higher value has been reported 
by Baars and colleague9 in Germany (67 per cent), while 
a lower frequency (7 per cent–8 per cent) has been 
recorded in the USA.1 10
In the Italian tested sample, 60 per cent of the ShS 
dogs analysed were homozygous for the absence of the 
mutated allele while only 6 per cent of the ShS dogs 
resulted affected with the MDR1 −/− genotype.
A high number of BoC dogs was tested in Italy (208) 
and the MDR1 mutant allele frequency was 4 per cent, 
with 93 per cent of homozygous clear animals and only 
7 per cent of carriers. No genetic affected dogs were 
observed (with −/− genotype).
Going on with collie- related breeds, tested BeC had a 
mutated allele frequency of 5 per cent and no homozygous 
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Table 2 Allelic and genotypic frequencies at MDR1 locus in affected breeds: breed and acronym, number of samples per 
breed (N), mutant MDR1 (MDR1−) allelic frequency (%), MDR1 genotypes (N; %)
Breed and acronym
Samples MDR1–frequency MDR1+/+ MDR1+/− MDR−/−
N % mutated allele N % genotype N % genotype N % genotype
Smooth Collie SmC 6 75 0 0 3 50 3 50
Rough Collie RoC 190 66 22 11 85 45 83 44
Australian Shepherd AuS 202 35 82 41 97 48 23 11
Shetland Sheepdog ShS 86 23 52 60 29 34 5 6
Whippet Whi 5 10 4 80 1 20 0 0
Old English Sheepdog OES 12 8 10 83 2 17 0 0
White Swiss Shepherd Dog WSS 27 7 23 85 4 15 0 0
Bearded Collie BeC 10 5 9 90 1 10 0 0
Border Collie BoC 208 4 193 93 15 7 0 0
Crossbreed Cro 31 15 24 78 5 16 0 6
mutated genotypes have been recorded in the breed in 
Italy. Two more breeds from the sheep herders’ group 
have been recorded to have MDR1 mutated allele: OES 
and WSS; the first one showed a frequency of mutant 
allele presence of 8 per cent, the second one 7 per cent; 
in no one of the two breeds mutant homozygous subjects 
were found.
The results obtained analysing 5 Whippet samples 
showed a 10 per cent frequency of the mutant allele, with 
one carrier dog.
No mutant allele was found in the other 22 breeds 
tested with a number of samples ranging from 1 to 4 
(Afghan Hound—AfH, American Staffordshire Terrier—
AST, Australian Cattle Dog—ACD, Australian Kelpie—
AuK, Borzoi—Bor, Belgian Shepherd—BeS, Bernese 
Mountain Dog—BMD, Saarloos Wolfdog—SaW, Central 
Asia Shepherd Dog—CAS, Czechoslovakian Wolfdog—
CzW, Dobermann—Dob, English Bulldog—EnB, Flat 
Coated Retriever—FCR, German Shepherd—GeS, 
Labrador Retriever—LaR, Maltese—Mal, Mudi—Mud, 
Rottweiler—Rot, Schipperkee—Sch, Shih Tzu—ShT, 
Tibetan Mastiff—TiM, Welsh Corgi Pembroke—WCP).
In the 31 Cro analysed, a mutated allele frequency in 
MDR1 gene of 15 per cent was recorded and six genotyp-
ically affected animals were diagnosed.
dIsCussIon
One hundred nine out of 811 dogs analysed, belonging 
respectively to RoC (44), AuS (23) and SmC3 breed, are 
homozygous for the mutated MDR1 allele; moreover, 242 
out of 811 are heterozygous for this mutation in 9 breeds 
and in the analysed crossbreed group. Forty- three per 
cent of all the tested dogs has at least one copy of the 
mutated MDR1 allele. These results underline the impor-
tance of an accurate knowledge of the genetic asset of 
canine pure breeds and of crossbreed in every clinical 
and reproductive approach.
The big sample of analysed Rough collies (n=190) 
reflects the census of this breed in Italy with 445 new 
entries in 2017. Only 11 per cent of the tested dogs are 
homozygous for the absence of the causative mutation, 
44 per cent are affected and 45 per cent are carriers.
The mutant allele frequency recorded in Italy in these 
two breeds (SmC=75 per cent; RoC=66 per cent) is in 
accordance with those reported in UK by Tappin and 
colleagues in 2012,4 73 per cent and 71 per cent for SmC 
and RoC populations, respectively, and also with the 64 
per cent reported in French RoC breed.11 Slightly lower 
results in MDR1 mutant frequency have been recorded in 
Germany: 59 per cent,7 55 per cent,12 in Japan 58.3 per 
cent,13 Australia 56 per cent14 and Brazil 61.2 per cent.3
In AuS, the MDR1 mutated allele frequency in Italy 
was calculated to be 35 per cent, a mean value consid-
ering it ranged from 15.7 per cent in Brazil2 to 46 per 
cent in UK.4 In the USA, the country of origin of AuS 
breed, Neff et al1 and Mealey and Meurs10 reported a 
mutant allele frequency of 17 per cent and 29 per cent, 
respectively. This could be considered a demonstration 
of the breeders’ attention and probably it is the reason 
of the low frequency of affected dogs registered in this 
breed considering, for example, that the highest number 
of entries in BoC in 2017 (3304) corresponded only to 
62 tested dogs. Moreover, it is worth mentioning that the 
high frequency of carriers needs a careful programming 
of the reproductive choices in these breeds.
The frequency of Italian ShS affected dogs is really 
lower than the 33 per cent frequency reported by Kawa-
bata et al in Japan13 and Baars et al in Germany.9 Higher 
frequencies have been described in Australia with 43 per 
cent11 and UK with 46 per cent.4 The same four base pair 
deletion in the canine ABCB1 gene was considered by all 
the cited authors.
The observed results are intermediate between the 
reported frequency of 2 per cent in UK and of 6 per cent 
in Germany.4 9 No MDR1 mutation was found in BoC, as 
reported by Firdova and colleagues in 201615 considering 
13 different European countries. Some variability in the 
BoC breed results could be supposed to be related to the 
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Figure 1 Average yearly variation in test frequency per breed per year (2012–2017); %.
existing division in two attitude/origin subpopulations: 
the show type mainly originated in Australian and the 
working type mainly originated in Great Britain.16
The frequencies observed in BeC are in contrast with 
those reported by Tappin and colleagues in 20124 from 
the country of origin of the breed where no mutated 
alleles were found in BeC. No one of the tested subjects 
was homozygous for the mutation, anyway it is important 
to know the presence of the mutated gene in BeC breed 
considering the reduced number of breeders in the breed 
(73 puppies entered in 2017 in Italian ENCI studbook).
Dekel reports a 37.5 per cent frequency of mutant allele 
in OES,17 which is the highest published frequency for the 
breed.4 7 15 For WSS, a slightly higher frequency was calcu-
lated by Gramer and colleagues in 2011 in Germany7 and 
by Dekel and colleagues in Israel in 2017,17 about 14 per 
cent and 16.7 per cent, respectively.
About Whi: the mutation has been described in the 
FCI as unrecognised long- haired whippet SiW in the USA 
with a 16–18 per cent frequency,1 10 but no mutation was 
found in the 14 samples analysed in UK by Tappin et al 
in 20124 and in the 53 samples tested by Monobe and 
colleagues in Brazil.3
MDR1 mutation test is available since 2008 when the 
first animals were tested for (2009 n=0, 2010 n=2, 2011 
n=3). A clear increase in the number of animals tested 
has been recorded since 2012 (n=44). In figure 1, the 
number of animals tested per breed per year and the total 
tested animal have been reported: a constant increase in 
the total number of tests has been shown, and a constant 
positive increase in tested BoC number is described. In 
the breeds where a negative variation has been recorded, 
it could be supposed that the produced litters are out of 
tested parents, so the genetic asset of the litter is known: 
‘clear by parentage’. Furthermore, the knowledge of the 
genetic combination causing ivermectin toxicosis is very 
important in small effective population sized breeds like 
SmC where carriers should be bred with mutation clear 
partners to ensure high levels of genetic variability and to 
reduce the pathological mutated allele frequency in the 
next generation. Furthermore, considering the obtained 
results, MDR1 mutation testing in crossbreed specimens 
where British sheepherding breeds’ ancestors could be 
supposed, could be very effective in the definition of 
appropriate therapeutic treatments.
In conclusion, the presented results underline the 
importance of an accurate knowledge of the MDR1 allele 
distribution in pedigree dogs to optimise clinical treat-
ments and reproductive management. The presence, 
the prevalence and the effects of the mutation should 
be taken into consideration in breeding strategy plan-
ning aiming to eliminate the causative mutation in the 
breeding stock, constantly monitoring inbreeding levels 
and limiting genetic variability losses.2 3 The supplied 
data could be used both to establish prevention and ther-
apeutic programmes and to trace down selection plans in 
the presented breeds considering both the differences in 
breed diffusion and the mutated allele frequencies in the 
different geographical areas.
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